Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Krapfenbauer

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The EPMA Journal|February 24, 2017
Identification of beta cell dysfunction at the pre-symptomatic stage of diabetes mellitus by novel analytical system: liquid biopsy measurements in femtogramsKurt Krapfenbauer
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2010
Improved enrichment and proteomic analysis of brain proteins with signaling function by heparin chromatographyKurt Krapfenbauer, Michael Fountoulakis
The EPMA Journal|December 4, 2012
Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-DiabetesJadranka Koehn, Kurt Krapfenbauer
The EPMA Journal|December 1, 2015
HTRF: a technology tailored for biomarker determination-novel analytical detection system suitable for detection of specific autoimmune antibodies as biomarkers in nanogram level in different body fluidsLukas Einhorn, Kurt Krapfenbauer
The EPMA Journal|February 28, 2013
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicineElisabeth Drucker, Kurt Krapfenbauer
The EPMA Journal|August 14, 2015
Identification of tumour-related proteins as potential screening markers by proteome analysis-protein profiles of human saliva as a predictive and prognostic toolKurt Krapfenbauer, Elisabeth Drucker, Dietmar Thurnher
The EPMA Journal|December 4, 2012
The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicineThomas Waerner, Dietmar Thurnher, Kurt Krapfenbauer
Electrophoresis|June 5, 2003
A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractionsKurt Krapfenbauer, Michael Fountoulakis, Gert Lubec
Progress in Neurobiology|May 22, 2003
Proteomics in brain research: potentials and limitationsGert Lubec, Kurt Krapfenbauer, Michael Fountoulakis
Electrophoresis|June 2, 2006
Large-scale identification of cytosolic mouse brain proteins by chromatographic prefractionationJoo-Ho Shin, Kurt Krapfenbauer, Gert Lubec
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The EPMA Journal|February 24, 2017
Identification of beta cell dysfunction at the pre-symptomatic stage of diabetes mellitus by novel analytical system: liquid biopsy measurements in femtogramsKurt Krapfenbauer
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2010
Improved enrichment and proteomic analysis of brain proteins with signaling function by heparin chromatographyKurt Krapfenbauer, Michael Fountoulakis
The EPMA Journal|December 4, 2012
Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-DiabetesJadranka Koehn, Kurt Krapfenbauer
The EPMA Journal|December 1, 2015
HTRF: a technology tailored for biomarker determination-novel analytical detection system suitable for detection of specific autoimmune antibodies as biomarkers in nanogram level in different body fluidsLukas Einhorn, Kurt Krapfenbauer
The EPMA Journal|February 28, 2013
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicineElisabeth Drucker, Kurt Krapfenbauer
The EPMA Journal|August 14, 2015
Identification of tumour-related proteins as potential screening markers by proteome analysis-protein profiles of human saliva as a predictive and prognostic toolKurt Krapfenbauer, Elisabeth Drucker, Dietmar Thurnher
The EPMA Journal|December 4, 2012
The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicineThomas Waerner, Dietmar Thurnher, Kurt Krapfenbauer
Electrophoresis|June 5, 2003
A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractionsKurt Krapfenbauer, Michael Fountoulakis, Gert Lubec
Progress in Neurobiology|May 22, 2003
Proteomics in brain research: potentials and limitationsGert Lubec, Kurt Krapfenbauer, Michael Fountoulakis
Electrophoresis|June 2, 2006
Large-scale identification of cytosolic mouse brain proteins by chromatographic prefractionationJoo-Ho Shin, Kurt Krapfenbauer, Gert Lubec
Pageof 3